Shahram Bahrami1,2, Nils Eiel Steen1,2, Alexey Shadrin1,2, Kevin O'Connell1,2, Oleksandr Frei1,2, Francesco Bettella1,2, Katrine V Wirgenes3, Florian Krull1,2, Chun C Fan4,5, Anders M Dale4,6,7,8, Olav B Smeland1,2, Srdjan Djurovic3,9, Ole A Andreassen1,2. 1. NORMENT Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. 2. Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway. 3. Department of Medical Genetics, Oslo University Hospital, Oslo, Norway. 4. Department of Radiology, University of California, San Diego, La Jolla. 5. Department of Cognitive Science, University of California, San Diego, La Jolla. 6. Multimodal Imaging Laboratory, University of California, San Diego, La Jolla. 7. Department of Psychiatry, University of California, San Diego, La Jolla. 8. Department of Neurosciences, University of California, San Diego, La Jolla. 9. NORMENT Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.
Abstract
Importance: People with major psychiatric disorders (MPDs) have a 10- to 20-year shorter life span than the rest of the population, and this difference is mainly due to comorbid cardiovascular diseases. Genome-wide association studies have identified common variants involved in schizophrenia (SCZ), bipolar disorder (BIP), and major depression (MD) and body mass index (BMI), a key cardiometabolic risk factor. However, genetic variants jointly influencing MPD and BMI remain largely unknown. Objective: To assess the extent of the overlap between the genetic architectures of MPDs and BMI and identify genetic loci shared between them. Design, Setting, and Participants: Using a conditional false discovery rate statistical framework, independent genome-wide association study data on individuals with SCZ (n = 82 315), BIP (n = 51 710), MD (n = 480 359), and BMI (n = 795 640) were analyzed. The UK Biobank cohort (n = 29 740) was excluded from the MD data set to avoid sample overlap. Data were collected from August 2017 to May 2018, and analysis began July 2018. Main Outcomes and Measures: The primary outcomes were a list of genetic loci shared between BMI and MPDs and their functional pathways. Results: Genome-wide association study data from 1 380 284 participants were analyzed, and the genetic correlation between BMI and MPDs varied (SCZ: r for genetic = -0.11, P = 2.1 × 10-10; BIP: r for genetic = -0.06, P = .0103; MD: r for genetic = 0.12, P = 6.7 × 10-10). Overall, 63, 17, and 32 loci shared between BMI and SCZ, BIP, and MD, respectively, were analyzed at conjunctional false discovery rate less than 0.01. Of the shared loci, 34% (73 of 213) in SCZ, 52% (36 of 69) in BIP, and 57% (56 of 99) in MD had risk alleles associated with higher BMI (conjunctional false discovery rate <0.05), while the rest had opposite directions of associations. Functional analyses indicated that the overlapping loci are involved in several pathways including neurodevelopment, neurotransmitter signaling, and intracellular processes, and the loci with concordant and opposite association directions pointed mostly to different pathways. Conclusions and Relevance: In this genome-wide association study, extensive polygenic overlap between BMI and SCZ, BIP, and MD were found, and 111 shared genetic loci were identified, implicating novel functional mechanisms. There was mixture of association directions in SCZ and BMI, albeit with a preponderance of discordant ones.
Importance: People with major psychiatric disorders (MPDs) have a 10- to 20-year shorter life span than the rest of the population, and this difference is mainly due to comorbid cardiovascular diseases. Genome-wide association studies have identified common variants involved in schizophrenia (SCZ), bipolar disorder (BIP), and major depression (MD) and body mass index (BMI), a key cardiometabolic risk factor. However, genetic variants jointly influencing MPD and BMI remain largely unknown. Objective: To assess the extent of the overlap between the genetic architectures of MPDs and BMI and identify genetic loci shared between them. Design, Setting, and Participants: Using a conditional false discovery rate statistical framework, independent genome-wide association study data on individuals with SCZ (n = 82 315), BIP (n = 51 710), MD (n = 480 359), and BMI (n = 795 640) were analyzed. The UK Biobank cohort (n = 29 740) was excluded from the MD data set to avoid sample overlap. Data were collected from August 2017 to May 2018, and analysis began July 2018. Main Outcomes and Measures: The primary outcomes were a list of genetic loci shared between BMI and MPDs and their functional pathways. Results: Genome-wide association study data from 1 380 284 participants were analyzed, and the genetic correlation between BMI and MPDs varied (SCZ: r for genetic = -0.11, P = 2.1 × 10-10; BIP: r for genetic = -0.06, P = .0103; MD: r for genetic = 0.12, P = 6.7 × 10-10). Overall, 63, 17, and 32 loci shared between BMI and SCZ, BIP, and MD, respectively, were analyzed at conjunctional false discovery rate less than 0.01. Of the shared loci, 34% (73 of 213) in SCZ, 52% (36 of 69) in BIP, and 57% (56 of 99) in MD had risk alleles associated with higher BMI (conjunctional false discovery rate <0.05), while the rest had opposite directions of associations. Functional analyses indicated that the overlapping loci are involved in several pathways including neurodevelopment, neurotransmitter signaling, and intracellular processes, and the loci with concordant and opposite association directions pointed mostly to different pathways. Conclusions and Relevance: In this genome-wide association study, extensive polygenic overlap between BMI and SCZ, BIP, and MD were found, and 111 shared genetic loci were identified, implicating novel functional mechanisms. There was mixture of association directions in SCZ and BMI, albeit with a preponderance of discordant ones.
Authors: Philip J Candilis; Cynthia M A Geppert; Kenneth E Fletcher; Charles W Lidz; Paul S Appelbaum Journal: Schizophr Bull Date: 2005-10-27 Impact factor: 9.306
Authors: Zhihong Zhu; Futao Zhang; Han Hu; Andrew Bakshi; Matthew R Robinson; Joseph E Powell; Grant W Montgomery; Michael E Goddard; Naomi R Wray; Peter M Visscher; Jian Yang Journal: Nat Genet Date: 2016-03-28 Impact factor: 38.330
Authors: Ole A Andreassen; Srdjan Djurovic; Wesley K Thompson; Andrew J Schork; Kenneth S Kendler; Michael C O'Donovan; Dan Rujescu; Thomas Werge; Martijn van de Bunt; Andrew P Morris; Mark I McCarthy; J Cooper Roddey; Linda K McEvoy; Rahul S Desikan; Anders M Dale Journal: Am J Hum Genet Date: 2013-01-31 Impact factor: 11.025
Authors: Martin Kircher; Daniela M Witten; Preti Jain; Brian J O'Roak; Gregory M Cooper; Jay Shendure Journal: Nat Genet Date: 2014-02-02 Impact factor: 38.330
Authors: Russell L McLaughlin; Dick Schijven; Wouter van Rheenen; Kristel R van Eijk; Margaret O'Brien; René S Kahn; Roel A Ophoff; An Goris; Daniel G Bradley; Ammar Al-Chalabi; Leonard H van den Berg; Jurjen J Luykx; Orla Hardiman; Jan H Veldink Journal: Nat Commun Date: 2017-03-21 Impact factor: 14.919
Authors: Lusi Zhang; Scot Kristian Hill; Bin Guo; Baolin Wu; Ney Alliey-Rodriguez; Seenae Eum; Paulo Lizano; Elena I Ivleva; James L Reilly; Richard S E Keefe; Sarah K Keedy; Carol A Tamminga; Godfrey D Pearlson; Brett A Clementz; Matcheri S Keshavan; Elliot S Gershon; John A Sweeney; Jeffrey R Bishop Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2021-10-29 Impact factor: 5.067
Authors: Tiril P Gurholt; Tobias Kaufmann; Oleksandr Frei; Dag Alnæs; Unn K Haukvik; Dennis van der Meer; Torgeir Moberget; Kevin S O'Connell; Olof D Leinhard; Jennifer Linge; Rozalyn Simon; Olav B Smeland; Ida E Sønderby; Adriano Winterton; Nils Eiel Steen; Lars T Westlye; Ole A Andreassen Journal: Transl Psychiatry Date: 2021-05-18 Impact factor: 6.222
Authors: Hillary L Ditmars; Mark W Logue; Rosemary Toomey; Ruth E McKenzie; Carol E Franz; Matthew S Panizzon; Chandra A Reynolds; Kristy N Cuthbert; Richard Vandiver; Daniel E Gustavson; Graham M L Eglit; Jeremy A Elman; Mark Sanderson-Cimino; McKenna E Williams; Ole A Andreassen; Anders M Dale; Lisa T Eyler; Christine Fennema-Notestine; Nathan A Gillespie; Richard L Hauger; Amy J Jak; Michael C Neale; Xin M Tu; Nathan Whitsel; Hong Xian; William S Kremen; Michael J Lyons Journal: Psychol Med Date: 2021-01-12 Impact factor: 10.592
Authors: Victor Mazereel; Johan Detraux; Davy Vancampfort; Ruud van Winkel; Marc De Hert Journal: Front Endocrinol (Lausanne) Date: 2020-10-09 Impact factor: 5.555
Authors: Igor Elman; Margaret Howard; Jacob T Borodovsky; David Mysels; David Rott; David Borsook; Mark Albanese Journal: Sci Rep Date: 2020-03-27 Impact factor: 4.379
Authors: Sarah Kittel-Schneider; Daniel Bury; Karolina Leopold; Sara Haack; Michael Bauer; Steffi Pfeiffer; Cathrin Sauer; Andrea Pfennig; Henry Völzke; Hans-Jörgen Grabe; Andreas Reif Journal: Front Psychiatry Date: 2020-04-22 Impact factor: 4.157